Ozased (Midazolam)

Midazolam, the active ingredient in Ozased, is a benzodiazepine presented as a strength/form for intravenous use. It is employed for sedation, anxiolysis, and seizure control in hospital settings. GNH USA supplies Ozased as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozased as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Midazolam is a short‑acting benzodiazepine that acts on the central nervous system to produce sedation and seizure control.

- Procedural sedation: Provides rapid onset sedation for short diagnostic or therapeutic procedures. - Pre‑operative anxiety: Reduces anxiety before surgery. - Status epilepticus: Controls ongoing seizures when first‑line therapy is insufficient. - Intensive care unit ICU sedation: Maintains light sedation for ventilated patients. - Seizure emergencies in the emergency department. - Induction of anesthesia for rapid sequence induction.

The      … …  ...

...

...